Arkolith/Insider Trading/CCXI/Form 4

Kanaya Susan M

EVP, CFO and Sec., DirectorChemoCentryx, Inc. (CCXI) · full profile →Form 4 · filed Aug 18, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.0M
Net Open-Market Flow
-$1.0M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 16, 2022Sell(S)20K$50.95$1.0M91K
Aug 16, 2022Option exercise(M)20K$10.86$216K111K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 16, 2022Option exercise(M)20K——35K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-046662) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML